# Maharashtra FDA issues notices to SRK, Ajay Devgn, Tiger Shroff over Vimal ads 2026-08-16T05:16:23+00:00 | Governance | Indian Opinion Desk Corroboration: 3 independent outlets The Maharashtra Food and Drug Administration (FDA), led by food safety chief Tukaram Mundhe, has sent a nine-page show-cause notice to actors Shah Rukh Khan, Ajay Devgn, and Tiger Shroff for indirectly promoting pan masala through advertisements for 'Vimal Elaichi'. The notice, issued on Friday, alleges the ads violate the Food Safety and Standards Act, 2006. The FDA's action is part of a wider crackdown on gutkha and pan masala containing tobacco or nicotine. According to some reports, the FDA is coordinating with police to invoke the Maharashtra Control of Organised Crime Act (MCOCA) in cases involving organised networks dealing in banned products. The actors have not yet publicly responded to the notices. ## Coverage - ndtvprofit.com - ndtv.com - livemint.com This story was synthesised by AI from the 3 sources linked above. Updated: this story now draws on 3 sources. Last updated 2026-08-16T05:35:32+00:00. Tags: Ajay Devgn, Maharashtra FDA, Shah Rukh Khan, Tiger Shroff, Tukaram Mundhe, Vimal Elaichi Canonical: https://indianopinion.org/maharashtra-fda-sends-notice-to-srk-ajay-devgn-tiger-shroff/ License: Summary and commentary (c) Indian Opinion, reusable with attribution. Facts belong to the linked sources. Cite: https://indianopinion.org/maharashtra-fda-sends-notice-to-srk-ajay-devgn-tiger-shroff/#story-in-brief How this brief was made: an AI model read the reports linked above and wrote this summary and analysis, which were published automatically. Published briefs are sampled every hour by an automated quality check; the editor verifies its findings and approves corrections, and corrected briefs carry a dated correction line. Stance labels are editorial classifications of how each outlet framed this story, assigned by the same model, not ratings of the outlets. We do no original reporting. Methodology: https://indianopinion.org/ai-use-policy/